Previous Close | 14.05 |
Open | 14.10 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 13.82 - 14.20 |
52 Week Range | 9.93 - 19.79 |
Volume | |
Avg. Volume | 374,634 |
Market Cap | 808.98M |
Beta (5Y Monthly) | 0.94 |
PE Ratio (TTM) | 11.58 |
EPS (TTM) | 1.20 |
Earnings Date | Nov 19, 2024 - Nov 25, 2024 |
Forward Dividend & Yield | 0.60 (4.32%) |
Ex-Dividend Date | Aug 27, 2024 |
1y Target Est | 16.07 |
EMBC's shares close higher following FDA clearance for its disposable patch pump for insulin delivery, expanding the target market with its availability for type 2 diabetes.
Embecta’s first patch pump features a larger insulin reservoir, based on feedback from people with Type 2 diabetes.